Metformin for the Treatment of Diabetes in Pregnancy
The purpose of this study is to determine whether metformin is effective and safe in the treatment of diabetes in pregnancy.
Status: Not yet recruiting (Phase 3). Started on January 1st, 2007.
Enrollment: 200 subjects
Study Type: Interventional
Study Design:
- Treatment
- Randomized
- Open Label
- Active Control
- Parallel Assignment
- Safety/Efficacy Study
Conditions:
Interventions:
- Drug: metformin
Eligibility
Inclusion Criteria:
pregnant women
GDM A2
diabetes mellitus type 2
singleton pregnancy
Exclusion Criteria:
diabetic nephropathy or proliferative retinopathy
cannot swallow tablets
- Gender
Female
- Mininum Age
18 Years
- Maximum Age
45 Years
- Healthy Volunteers
No
Resources
Source: Soroka University Medical Center
Authority: Israel: Ministry of Health
Locations
-
Division of Obstetrics and Gynecology, Soroka University Medical Center
Beer-Sheva
Israel
Officials
Boaz Sheizaf, MD (Principal Investigator, division of obstetrics and gynecology, soroka university medical center)
Sponsors
Soroka University Medical Center (Lead Sponsor)
Ben-Gurion University of the Negev (Collaborator)
References
None.
Links
None.
- Date Verified
- December 1st, 2006
- First Received
- December 20th, 2006
- Last Changed
- December 20th, 2006
Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.